Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. [electronic resource]
Producer: 20071129Description: e20-3 p. digitalISSN:- 1592-8721
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- B-Cell Activating Factor -- blood
- B-Lymphocytes -- drug effects
- Bone Marrow -- pathology
- Cell Lineage
- Cells, Cultured -- drug effects
- Cyclophosphamide -- administration & dosage
- Cytokines -- blood
- Drug Therapy, Combination
- Female
- Humans
- Immunologic Factors -- administration & dosage
- Lymphopoiesis -- physiology
- Middle Aged
- Myelopoiesis -- physiology
- Neutropenia -- chemically induced
- Rituximab
- Time Factors
- Vidarabine -- administration & dosage
- Waldenstrom Macroglobulinemia -- blood
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.